Clinical Trial Update: A Multicenter Phase 2a Clinical Study to Evaluate SIM0278 in Subjects With Active Lupus Nephritis [Phase 2]

View source ↗

Summary

A multicenter Phase 2a study evaluating SIM0278 in active lupus nephritis is planned, with the trial status listed as not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis

Drugs mentioned

• SIM0278

Snippet

Sponsor: Simcere Pharmaceutical Co., Ltd | Conditions: Lupus Nephritis | Phase 2 | Status: NOT_YET_RECRUITING